Icon

SPRAVATO (nda211243)- (EQ 28MG BASE)

ESKETAMINE HYDROCHLORIDE JANSSEN PHARMS
EQ 28MG BASE
Yes No
2040-Feb-18 Expired
None None
None No
SPRAVATO ® is a non-competitive N-methyl D-aspartate (NMDA) receptor antagonist indicated, in conjunction with an oral antidepressant, for the treatment of: • Treatment-resistant depression (TRD) in adults. • Depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.
0 0 0
Total Other Developers 2
Drugs with Suitability No
EQ 28MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.